Biotechnology Venture Readiness Program 2025
A Virtual/Hybrid 9-week program - free for Saudi and Foreign biotech innovators at every stage
What to Expect from the Program?
It’s a precision-built experience for biotech founders who are ready to lead, not just build. Whether you're refining your molecule, validating your platform, or preparing for clinical trials, this program meets you where you are - and moves you forward.
Scientific & Clinical Strategy
- Sharpen your development roadmap - from preclinical to clinical milestones
- Navigate regulatory pathways with confidence (SFDA, FDA, EMA)
- Understand trial design, patient recruitment, and data integrity
Founder Leadership & Narrative
- Craft a venture story that commands respect - from scientists to investors
- Communicate your science with clarity, pride, and strategic intent
- Build founder resilience and decision-making frameworks for high-stakes environments
Venture Development & Fundraising
- Position your startup for venture capital, strategic partnerships, and grants
- Structure your IP, equity, and governance for long-term strength
- Learn how biotech investors think - and how to speak their language
Ecosystem Integration
- Engage with Saudi Arabia’s biotech vision and global innovation networks
- Explore partnership pathways with hospitals, universities, and pharma
- Understand local banking, legal, and compliance essentials for biotech ventures
Personalized Guidance
- 1:1 advisory sessions with domain experts
- Peer reviews and founder roundtables
- Strategic feedback on pitch decks, regulatory plans, and partnership proposals
Summary
This program doesn’t just prepare you for the next step - it dignifies the journey you’re already on. Every session is designed to elevate your leadership, validate your science, and position your venture for impact.
Biotechnology Venture Readiness Program 2025
APPLY AS A STARTUP OR BIOTECH INNOVATOR TEAM (FREE FOR SAUDI AND FOREIGN STARTUPS)
Biotech founders don’t need hand-holding – they need clarity, traction, and strategic lift. Biotechnology Venture Readiness Program 2025 is built for innovators at every stage, from concept to clinical, who are ready to sharpen their venture story, validate their science, and engage with partners who understand the stakes. We cover what matters: regulatory readiness, IP strategy, clinical pathways, investor alignment, and founder leadership. Every topic that moves a biotech venture forward is on the table. If you’re building something that deserves to be seen, funded, and scaled – this is where you start.
Startup Categories Featured
Bio Pharmaceuticals
Therapeutics, biologics, and precision drug development
Advanced Therapies
Cell & gene therapy, novel treatments
MedTech & Diagnostics
Medical devices, lab technologies, digital diagnostics
Bioinformatics, HealthTech
AI-powered platforms, biotech software, genomic data tools
Program Includes Advanced Knowledge & Practice
Explore global biotech trends and Saudi Arabia’s national strategy. Learn from success stories, infrastructure insights, and entry pathways that align with Vision 2030. Founders gain clarity on how to position their ventures within both global and local ecosystems
Assess your biotech venture’s scalability, regulatory alignment, and product development maturity. Includes readiness checklists, technical roadmapping, IP strategy development, and planning for clinical, manufacturing, and market access
Define your market opportunity through TAM/SAM/POSM analysis. Build stakeholder maps and early validation plans to strengthen credibility, refine product-market fit, and prepare for investor and partner engagement
Navigate SFDA and global regulatory pathways, design clinical trials, and understand HTA principles. Founders receive tools to align evidence generation with approval requirements, payer expectations, and long-term adoption strategies
Understand key IP types - patents, trade secrets, and proprietary data - and how to protect biotech innovation across Saudi, GCC, and global systems. Learn licensing models for joint development and commercialization. Includes a focused workshop on building IP defensibility and communicating it to investors
Master biotech financials - from investor-ready data rooms to valuation strategies that monetize IP and licensing. Explore funding instruments beyond equity, including SAFE, convertible notes, and venture debt. Learn how to align science, finance, and strategy in board decisions, and how to pivot deep-tech ventures into scalable, investor-attractive businesses
Craft compelling biotech branding and storytelling decks tailored for non-scientific audiences. Prepare investor materials, simulate pitch meetings, and refine your narrative - including how to communicate IP assets, exclusivity, and defensibility - to lead fundraising conversations with clarity and confidence
Identify core team roles, build scientific and strategic advisory boards, and prepare governance structures for accelerator onboarding. Includes founder selection criteria, mentorship access, and a final in-person forum in Riyadh to connect with ecosystem stakeholders, investors and showcase venture leadership
Unlock opportunities to pilot your technology with hospitals, research centers, and clinical partners. Gain visibility with ecosystem players and explore strategic collaborations that accelerate validation and adoption
Tap into a curated network of biotech investors, venture builders, and innovation platforms. Receive introductions, feedback, and matchmaking support to position your venture for funding and long-term growth
THANK YOU FOR YOUR APPLICATION. Selection in progress...
APPLICATION 2025
THANK YOU FOR YOUR APPLICATION. Selection in progress...
APPLICATION DEADLINE - 23 SEPTEMBER 2025, 11:59 PM
You will be notified by email shortly. If a "Thank you" message appeared on the screen upon submission - we received your application
You will be notified by email shortly. If a “Thank you” message appeared on the screen upon submission – we received your application
Led by Global Biotech Experts
Expert-Led. Founder-Focused. The Program is powered by top domain professionals. We’re proud to present our distinguished lecturers and mentors
Employee Name
Job Title
Employee Name
Job Title
Employee Name
Job Title
Employee Name
Job Title
Prof. Ahmed
Alaskar
Dr. Mobarak
Almulhim
Dr. Abdallah A.
Adlan
Mr. Jeff
Stinson
Mr. Sultan
Almansour
Dr. Abdullah K.
Alshememry
Dr. George
Syrmalis
Dr. Tariq
Tawfiq Massad
Dr. George
Voren
Mr. Deepak
Mansukhani
Mr. Fadzhairi
Jabar
Dr. Ehab
AlShamleh
Mr. Osama K.
Bin Salman
Dr. Matteo
Turi
Dr. Ana
Baroni
Dr. Mariam
AlEissa
Mr. Jalal
Awad
Dr. Melya Hughes
Crameri
Dr. Sascha
Berger
Mr. Adel
Alghamdi
Dr. Budoor
AlMansour
Dr. Yun Kyoung
Kang
Dr. Tanveer
Ahmad
Mr. Ali
Djedid
Galiya
Potapchuk
Startup Eligibility Criteria
The Biotech Venture Readiness Program is open to founders and teams who are building biotech ventures with scientific depth and strategic ambition. We welcome startups across all stages - from concept to clinical - provided they meet the following criteria
Biotech Focus
Your venture must be rooted in biotechnology - therapeutics, diagnostics, digital health, platform technologies, or enabling tools
Founder-Led
Applications must come from founders or core team members actively leading the venture’s development
Saudi & Global Builders
We welcome Saudi-based startups and international teams committed to engaging with the Kingdom’s biotech ecosystem
Stage-Agnostic, Strategy-Driven
Whether you're refining your idea or preparing for trials, you must demonstrate clarity of purpose and readiness to engage
Commitment to Growth
Founders must be available to participate in Riyadh-based Forum (December 2025) and commit to the full duration of the virtual program
Language Proficiency
Sessions are delivered in English, mainly (90%) in virtual format
Trusted By
Program Support & Partners, we’re proud to cooperate
Participation Commitment & Program Benefits
The Biotech Venture Readiness Program is offered free of charge – but it is not free of expectations. Founders who commit fully to the journey will unlock meaningful benefits designed to elevate their venture and expand their network
FULL PARTICIPATION REQUIRED TO:
- Be invited to the final Selection Forum in Riyadh, where top ventures will present to investors, advisors, and ecosystem leaders
- Receive personalized introductions to domain experts, mentors, and potential partners
- Obtain a Certificate of Completion
- Be considered for onboarding into the full accelerator program
- Gain access to exclusive follow-up clinics, investor prep sessions, and strategic advisory slots
- Be featured in program publications, media coverage, and ecosystem showcases
- Join a growing alumni network of biotech founders shaping Saudi Arabia’s innovation landscape
FULL PARTICIPATION REQUIRED TO:
- Be invited to the final Selection Forum in Riyadh, where top ventures will present to investors, advisors, and ecosystem leaders
- Receive personalized introductions to domain experts, mentors, and potential partners
- Obtain a Certificate of Completion
- Be considered for onboarding into the full accelerator program
- Gain access to exclusive follow-up clinics, investor prep sessions, and strategic advisory slots
- Be featured in program publications, media coverage, and ecosystem showcases
- Join a growing alumni network of biotech founders shaping Saudi Arabia’s innovation landscape
FAQ
What is the Biotechnology Venture Readiness Program 2025?
The Biotechnology Venture Readiness Program 2025 is a strategic pre-accelerator designed to equip biotech startups with the tools, insights, and connections needed to scale. It focuses on scientific validation, regulatory readiness, and venture development – preparing founders for investment, partnerships, and long-term impact.
The program begins at the end of September 2025 and runs for over 9 weeks, culminating in a Final Selection Forum in Riyadh, where top-performing startups will present to ecosystem leaders, investors, and strategic partners.
Who is behind the program?
The program is established and run by Saudi company: All Care Group for Investment in partnership with Value Chain Global. It is supported by Monsha’at, the Small and Medium Enterprises General Authority of Saudi Arabia, which leads the development and regulation of the SME sector in alignment with Vision 2030.
In addition, the program is backed by a network of top Saudi and global experts and organizations – including specialists in biotechnology, venture development, regulatory strategy, and innovation policy – ensuring that selected startups receive world-class guidance throughout the journey.
When will sessions take place?
Virtual sessions will be held twice per week.
The introductory session will be at the end of September.
The full schedule will be announced after the selection process.
Founders are expected to attend all sessions to remain eligible for program benefits.
What is the application deadline?
The deadline to apply is 23 September 2025 at 11:59 PM Saudi time (GMT +3).
Applications submitted after this time will not be considered.
How will selected startups be notified?
All applicants – whether accepted or not – will receive an official email notification after the selection process.
Selected startups will receive onboarding instructions and session details.
How can I join the program as a mentor or lecturer?
Biotechnology Venture Readiness Program 2025 welcomes experienced professionals, scientists, and ecosystem builders to contribute as mentors or guest lecturers. If you have expertise in biotech innovation, venture development, regulatory strategy, or founder coaching, we invite you to express interest.
To join:
• Submit a short bio and area of expertise via this link
• Indicate your availability between late September and mid-December 2025
• Selected mentors will be contacted for onboarding and session planning
The program values voices that elevate founders with clarity, rigor, and global perspective.
Saudi Biotechnology Accelerator
Pioneering Saudi-based Biotechnology Accelerator, advancing biotech innovators’ journey, and helping to excel in the Global Markets, while contributing to the Saudi Biotechnology Ecosystem establishment and growth